Directory
>
David Peritt
David Peritt
Consultant | Korro Bio, Inc.
Chicago, Illinois, United States
David Peritt
Summary
David Peritt is a seasoned expert in the field of biotechnology and immunology, specializing in the development of innovative therapeutic solutions, particularly in gene therapy and cell-based treatments. As the Founder and Chief Scientific Officer of Lupagen, he leads efforts to revolutionize bedside cell therapy with a focus on patient safety and cost efficiency. David's extensive experience includes leadership roles in renowned organizations such as Pfizer and Johnson & Johnson, where he contributed to groundbreaking advancements in CAR-T therapies and regenerative medicine. He is also an adjunct professor at Northwestern University, where he shares his expertise with the next generation of biotech professionals. With multiple patents and board memberships to his name, David is recognized as a thought leader in the biopharmaceutical industry. His passion for transforming healthcare through science is evident in his commitment to developing therapies that broaden access and improve patient outcomes.
David Peritt
Work Experience
Consultant at
Guidepoint
January 2021 - Present
Scientific Advisory Board Member at
Korro Bio, Inc.
January 2021 - Present
Founder and CSO at
Lupagen
January 2017 - Present
Adjunct Professor at
Northwestern University
April 2015 - Present
Science & Technology Committee Member at
Alliance for Regenerative Medicine
January 2015 - Present
Chief Scientific Officer at
Sigilon Therapeutics, Inc.
June 2017 - April 2021
Program Lead, Tolerance and Cell Therapy at
Pfizer
February 2016 - May 2017
Biosimilars Biology and Immunology at
Hospira
January 2012 - January 2015
Strategic Corporate Investor, Cell Therapy and Regenerative Medicine at
Hospira
July 2008 - November 2011
Director at
Johnson & Johnson
January 2005 - January 2008
Head Of Research And Development at
Therakos
June 2001 - June 2007
Senior Research Scientist at
Centocor
January 1998 - January 2001
Graduate School at
University Of Pennsylvania
January 1992 - January 1998
Associate Scientist at
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
January 1991 - January 1992
Graduate Student at
Hadassa Medical centers the hebrew university jerusalem
January 1988 - January 1991
Scientist at
US Army
January 1986 - January 1987
Research Intern at
USDA
January 1985 - January 1985
David Peritt
Education
University of Pennsylvania, Doctor Of Philosophy (Ph.D.)
Hebrew University of Jerusalem, Master Of Science (Msc)
University of Maryland, Bachelor Of Science (B.Sc.)
Frequently Asked Questions about David Peritt
What is David Peritt email address?
David Peritt's primary email address is *******@korrobio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does David Peritt work for?
David Peritt is a Consultant at Korro Bio, Inc., a company specializing in Commercial physical research.
Where David Peritt graduated from?
David Peritt holds a degree in Immunology from University of Pennsylvania.
How can I directly contact David Peritt?
To contact David Peritt directly, you can use the email address *******@korrobio.com. Complete contact information is available upon registration with Muraena.
Who is David Peritt?
David Peritt is a seasoned expert in the field of biotechnology and immunology, specializing in the development of innovative therapeutic solutions, particularly in gene therapy and cell-based treatments. As the Founder and Chief Scientific Officer of Lupagen, he leads efforts to revolutionize bedside cell therapy with a focus on patient safety and cost efficiency. David's extensive experience includes leadership roles in renowned organizations such as Pfizer and Johnson & Johnson, where he contributed to groundbreaking advancements in CAR-T therapies and regenerative medicine. He is also an adjunct professor at Northwestern University, where he shares his expertise with the next generation of biotech professionals. With multiple patents and board memberships to his name, David is recognized as a thought leader in the biopharmaceutical industry. His passion for transforming healthcare through science is evident in his commitment to developing therapies that broaden access and improve patient outcomes.
David`s contact details
*******@korrobio.com
************@lupagen.com
************@pfizer.com
************@sigilon.com
Colleagues
VP, Head of CMC
SVP, HR People & Culture
Director Board of Directors
Vice President
Senior Vice President, Strategy And Portfolio Planning
Vice President, Translational Sciences
Vice President, Head of CNS Biology
Vice President, Corporate Strategy & Portfolio Planning
Senior Vice President, Head of Platform Research - RNA Editing
Chief Financial Officer